• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Xpert Ultra Can Unambiguously Identify Specific Rifampin Resistance-Conferring Mutations.

作者信息

Ng Kamela C S, van Deun Armand, Meehan Conor J, Torrea Gabriela, Driesen Michèle, Gabriëls Siemon, Rigouts Leen, André Emmanuel, de Jong Bouke C

机构信息

Unit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium

Unit of Mycobacteriology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

出版信息

J Clin Microbiol. 2018 Aug 27;56(9). doi: 10.1128/JCM.00686-18. Print 2018 Sep.

DOI:10.1128/JCM.00686-18
PMID:29925643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6113491/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2879/6113491/33a8be465109/zjm9990960710002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2879/6113491/78b6972d4d68/zjm9990960710001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2879/6113491/33a8be465109/zjm9990960710002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2879/6113491/78b6972d4d68/zjm9990960710001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2879/6113491/33a8be465109/zjm9990960710002.jpg

相似文献

1
Xpert Ultra Can Unambiguously Identify Specific Rifampin Resistance-Conferring Mutations.Xpert Ultra 能够明确鉴定出特定的利福平耐药性相关突变。
J Clin Microbiol. 2018 Aug 27;56(9). doi: 10.1128/JCM.00686-18. Print 2018 Sep.
2
The New Xpert MTB/RIF Ultra: Improving Detection of and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.新型Xpert MTB/RIF Ultra：在适用于即时检测的检测方法中提高对结核分枝杆菌的检测及利福平耐药性检测
mBio. 2017 Aug 29;8(4):e00812-17. doi: 10.1128/mBio.00812-17.
3
Automatic Identification of Individual Gene Mutations Responsible for Rifampin Resistance in Mycobacterium tuberculosis by Use of Melting Temperature Signatures Generated by the Xpert MTB/RIF Ultra Assay.利用 Xpert MTB/RIF Ultra 检测生成的解链温度特征自动识别结核分枝杆菌中导致利福平耐药的个体基因突变。
J Clin Microbiol. 2019 Dec 23;58(1). doi: 10.1128/JCM.00907-19.
4
The Application of Xpert Mycobacterium tuberculosis/Rifampicin, Quantitative Polymerase Chain Reaction and High Resolution Melting Curve in the Diagnosis of Superficial Lymph Node TB.Xpert 结核分枝杆菌/利福平检测、实时荧光定量聚合酶链反应和高分辨率熔解曲线在浅表淋巴结结核诊断中的应用。
Curr Pharm Biotechnol. 2019;20(12):1044-1054. doi: 10.2174/1389201020666190716104131.
5
Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the gene of clinical isolates in Shanghai, PR China.中国上海临床分离株中 基因的利福平耐药决定区的利福平耐药相关突变。
J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001317. Epub 2021 Jan 28.
6
Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.在巴基斯坦开伯尔-普赫图赫瓦省使用Xpert MTB/RIF检测结核分枝杆菌临床分离株rpoB基因81bp利福平耐药决定区的利福平耐药突变：一项回顾性研究
BMC Infect Dis. 2016 Aug 12;16:413. doi: 10.1186/s12879-016-1745-2.
7
How Well Do Routine Molecular Diagnostics Detect Rifampin Heteroresistance in Mycobacterium tuberculosis?常规分子诊断检测结核分枝杆菌利福平异质性耐药的效果如何？
J Clin Microbiol. 2019 Oct 23;57(11). doi: 10.1128/JCM.00717-19. Print 2019 Nov.
8
The performance of the Xpert MTB/RIF Version G4 in a low tuberculosis incidence setting.Xpert MTB/RIF G4版本在结核病低发病率环境中的性能。
Pathology. 2022 Feb;54(1):123-125. doi: 10.1016/j.pathol.2021.03.007. Epub 2021 Jul 1.
9
Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis.Xpert MTB/RIF检测法与GenoType MTBDRplus DNA探针检测结核分枝杆菌中利福平耐药相关突变的比较
PLoS One. 2016 Apr 7;11(4):e0152694. doi: 10.1371/journal.pone.0152694. eCollection 2016.
10
Novel rapid PCR for the detection of Ile491Phe rpoB mutation of Mycobacterium tuberculosis, a rifampicin-resistance-conferring mutation undetected by commercial assays.新型快速 PCR 检测结核分枝杆菌 Ile491Phe rpoB 突变，该突变是商业检测方法无法检测到的利福平耐药相关突变。
Clin Microbiol Infect. 2017 Apr;23(4):267.e5-267.e7. doi: 10.1016/j.cmi.2016.12.009. Epub 2016 Dec 18.

引用本文的文献

1
Probe amplifications in the Xpert MTB/RIF Ultra assay for non-tuberculous mycobacteria identified from diabetes mellitus and chronic kidney disease patients in Ethiopia.针对从埃塞俄比亚糖尿病和慢性肾病患者中鉴定出的非结核分枝杆菌，在Xpert MTB/RIF Ultra检测中的探针扩增情况。
Sci Rep. 2025 May 27;15(1):18465. doi: 10.1038/s41598-025-03716-y.
2
Limitations of the MTB/RIF Assay: An Xpert Review of 4 Clinical Cases.MTB/RIF检测的局限性：4例临床病例的Xpert回顾
Open Forum Infect Dis. 2025 Mar 5;12(4):ofaf132. doi: 10.1093/ofid/ofaf132. eCollection 2025 Apr.
3
Culture-Free Whole Genome Sequencing of Using Ligand-Mediated Bead Enrichment Method.

本文引用的文献

1
Recurrent tuberculosis in the pre-elimination era.消除阶段前的复发性结核病。
Int J Tuberc Lung Dis. 2018 Feb 1;22(2):139-150. doi: 10.5588/ijtld.17.0590.
2
Potential Application of Digitally Linked Tuberculosis Diagnostics for Real-Time Surveillance of Drug-Resistant Tuberculosis Transmission: Validation and Analysis of Test Results.数字关联结核病诊断技术在耐多药结核病传播实时监测中的潜在应用：检测结果的验证与分析
JMIR Med Inform. 2018 Feb 27;6(1):e12. doi: 10.2196/medinform.9309.
3
Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis.
使用配体介导的磁珠富集法进行无培养全基因组测序。
Open Forum Infect Dis. 2024 Jun 15;11(7):ofae320. doi: 10.1093/ofid/ofae320. eCollection 2024 Jul.
4
GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis.GeneXpert MTB/RIF Ultra 对检测结核分枝杆菌中罕见 rpoB 突变的性能。
BMC Res Notes. 2023 Jul 14;16(1):146. doi: 10.1186/s13104-023-06394-z.
5
Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda.在耐多药结核病治疗开始前，Xpert MTB/RIF G4与Xpert Ultra之间利福平药敏结果不一致：乌干达的一例病例报告。
J Clin Tuberc Other Mycobact Dis. 2021 Nov 6;25:100286. doi: 10.1016/j.jctube.2021.100286. eCollection 2021 Dec.
6
Identification and Characterization of Mycobacterial Species Using Whole-Genome Sequences.基于全基因组序列鉴定和描述分枝杆菌菌种。
Methods Mol Biol. 2021;2314:399-457. doi: 10.1007/978-1-0716-1460-0_19.
7
Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda.乌干达开始接受耐多药结核病治疗的患者中，用于检测利福平耐药性的GeneXpert MTB/RIF重复检测结果的不一致性。
Open Forum Infect Dis. 2021 Apr 2;8(6):ofab173. doi: 10.1093/ofid/ofab173. eCollection 2021 Jun.
8
Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis.Xpert Ultra 与 Xpert MTB/RIF 检测疑似肺结核成人肺结核和利福平耐药性的比较。
Cochrane Database Syst Rev. 2021 Feb 22;2:CD009593. doi: 10.1002/14651858.CD009593.pub5.
9
Comparison of metagenomic next-generation sequencing technology, culture and GeneXpert MTB/RIF assay in the diagnosis of tuberculosis.宏基因组下一代测序技术、培养法和GeneXpert MTB/RIF检测法在结核病诊断中的比较
J Thorac Dis. 2020 Aug;12(8):4014-4024. doi: 10.21037/jtd-20-1232.
10
False Rifampicin Resistance in Xpert Ultra Applied to Lymph Node Aspirate: A Case Report.应用于淋巴结穿刺液的Xpert Ultra检测出现假利福平耐药：一例报告
Open Forum Infect Dis. 2020 Jun 2;7(6):ofaa204. doi: 10.1093/ofid/ofaa204. eCollection 2020 Jun.
全基因组分析多药和广泛耐药结核分枝杆菌。
Nat Genet. 2018 Feb;50(2):307-316. doi: 10.1038/s41588-017-0029-0. Epub 2018 Jan 22.
4
The New Xpert MTB/RIF Ultra: Improving Detection of and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.新型Xpert MTB/RIF Ultra：在适用于即时检测的检测方法中提高对结核分枝杆菌的检测及利福平耐药性检测
mBio. 2017 Aug 29;8(4):e00812-17. doi: 10.1128/mBio.00812-17.
5
Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination.诊断技术的连通性：加强监测并加速消除结核病
Int J Tuberc Lung Dis. 2016 Aug;20(8):999-1003. doi: 10.5588/ijtld.16.0015.
6
Rifampin drug resistance tests for tuberculosis: challenging the gold standard.利福平耐药结核病检测：挑战金标准。
J Clin Microbiol. 2013 Aug;51(8):2633-40. doi: 10.1128/JCM.00553-13. Epub 2013 Jun 12.
7
Tuberculosis drug resistance mutation database.结核病耐药性突变数据库。
PLoS Med. 2009 Feb 10;6(2):e2. doi: 10.1371/journal.pmed.1000002.